Elite Pharmaceuticals, Inc. Income Tax Credits and Adjustments
Elite Pharmaceuticals, Inc. (ELTP) reported Income Tax Credits and Adjustments of $857.38 thousand for the 12-month period ending 2022-03-31, per its 10-K filed 2023-06-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxCreditsAndAdjustments · last filed 2023-06-29
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for the quarter ending 2014-06-30 was -$3.25K.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for the quarter ending 2014-03-31 was $292.61M.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for the quarter ending 2013-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for the quarter ending 2013-09-30 was $2.27K, a 121.80% increase year-over-year.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for fiscal 2022 was $857.38K, a 9.17% decline from fiscal 2021.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for fiscal 2021 was $943.91K.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for fiscal 2019 was $676.02K, a 35.36% decline from fiscal 2018.
- Elite Pharmaceuticals, Inc. income tax credits and adjustments for fiscal 2018 was $1.05M, a 44.00% decline from fiscal 2017.
| Period end | Income Tax Credits and Adjustments 3 month | Income Tax Credits and Adjustments 6 month | Income Tax Credits and Adjustments 9 month | Income Tax Credits and Adjustments 12 month | Income Tax Credits and Adjustments 12 month as first filed |
|---|---|---|---|---|---|
| 2022-03-31 | $857.38K 10-K · filed 2023-06-29 | ||||
| 2021-03-31 | $943.91K 10-K · filed 2022-06-29 | $904.53K 10-K · filed 2021-06-14 | |||
| 2019-03-31 | $676.02K 10-K · filed 2020-06-29 | ||||
| 2018-03-31 | $1.05M 10-K · filed 2019-06-21 | ||||
| 2017-03-31 | $1.87M 10-K · filed 2018-06-14 | ||||
| 2016-03-31 | $520.45K 10-K · filed 2018-06-14 | $520.45M 10-K · filed 2016-06-15 | |||
| 2015-03-31 | $3.25K 10-K · filed 2017-06-14 | $3.25K 10-K · filed 2015-06-15 | |||
| 2014-06-30 | -$3.25K 10-Q · filed 2014-08-14 | $292.61M derived: sum of 2 quarters · filed 2016-06-15 | $292.61M derived: sum of 3 quarters · filed 2016-06-15 | $292.61M derived: sum of 4 quarters · filed 2016-06-15 | |
| 2014-03-31 | $292.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-15 | $292.61M derived: sum of 2 quarters · filed 2016-06-15 | $292.61M derived: sum of 3 quarters · filed 2016-06-15 | $292.61M 10-K · filed 2016-06-15 | -$292.61K 10-K · filed 2014-06-30 |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-14 | $2.27K derived: sum of 2 quarters · filed 2014-02-14 | $2.27K 10-Q · filed 2014-02-14 | -$355.47K derived: sum of 4 quarters · filed 2014-06-30 | |
| 2013-09-30 | $2.27K 10-Q · filed 2013-11-14 | $2.27K 10-Q · filed 2013-11-14 | -$355.47K derived: sum of 3 quarters · filed 2014-06-30 | -$355.47K derived: sum of 4 quarters · filed 2014-06-30 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | -$357.74K derived: sum of 2 quarters · filed 2014-06-30 | -$357.74K derived: sum of 3 quarters · filed 2014-06-30 | -$356.72K derived: sum of 4 quarters · filed 2014-06-30 | |
| 2013-03-31 | -$357.74K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | -$357.74K derived: sum of 2 quarters · filed 2014-06-30 | -$356.72K derived: sum of 3 quarters · filed 2014-06-30 | -$353.72K 10-K · filed 2014-06-30 | |
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $1.02K derived: sum of 2 quarters · filed 2014-02-14 | $4.02K 10-Q · filed 2014-02-14 | ||
| 2012-09-30 | $1.02K 10-Q · filed 2013-11-14 | $4.02K 10-Q · filed 2013-11-14 | |||
| 2012-06-30 | -$3.00K 10-Q · filed 2013-08-14 | ||||
| 2012-03-31 | -$483.95K 10-K · filed 2013-06-21 | ||||
| 2011-03-31 | -$301.41K 10-K · filed 2012-06-29 |